Assistant Professor, University of MIchigan
Urology
Dr. Todd M. Morgan, MD
|
|
Give Review
Todd Morgan works in the field of Urology. He went to medical school at Harvard Medical School. Harvard Medical School is a top medical college. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He received awards:"Outstanding Reviewer in Prostate Cancer", "CMS Meaningful Use Stage 1 Certification", "Best Poster", "Best of AUA/JUA Annual Meeting", "Gerald P. Murphy Scholar", "CaPSURE Scholar", "International Volunteers in Urology Scholar", "Scholar-in-Training Award", "Warren H. Chapman Research Award", "First Prize Poster", "First Prize Resident Paper" and "Young Investigator Award". Doctor Todd M. Morgan, MD is a published doctor. He has 43 papers published. The most current publication "Thymic stromal organization is regulated by the specificity of T cell receptor/major histocompatibility complex interactions." Todd M. Morgan, MD accepts all Medicare patients.
Publications
- Variation in the use of postoperative radiotherapy among high-risk patients following radical Prostatectomy.
- Prognostic value of percent Gleason grade 4 at Prostate biopsy on predicting Prostatectomy pathology and recurrence.
- Patient Psoas Muscle Mass as a Predictor of Complications and Survival After Radical Cystectomy.
- Clinicopathologic characteristics of anterior prostate Cancer (APC), including correlation with previous biopsy pathology.
- Assessment of long-term outcomes associated with urinary prostate Cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy.
- Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk-Stratification Algorithm Based on Percutaneous Renal Mass Biopsy and Mass Size for A...
- Molecular and Immunohistochemical Characterization Reveals Novel BRAF Mutations in Metanephric Adenoma.
- HRAS mutations are frequent in inverted urothelial neoplasms.
- Prostate Cancer early detection, version 1.2014.
- THE USE OF SOCIAL MEDIA IN ENDOUROLOGY: AN ANALYSIS OF THE 2013 WORLD CONGRESS OF ENDOUROLOGY MEETING.
- Understanding the Relationship Between Tumor Size, Gland Size, and Disease Aggressiveness in Men With Prostate Cancer.
- A risk-adjusted definition of biochemical recurrence after radical Prostatectomy.
- Papillary renal Cell carcinoma revisited: a comprehensive histomorphologic study with outcome correlations.
- Sharpening the focus on causes and timing of readmission after radical cystectomy for Bladder cancer.
- Comparison of prostate Cancer diagnosis in patients receiving unrelated urological and non-urological Cancer care.
- Incidence and Predictors of Understaging in Patients with Clinical T1 Urothelial Carcinoma Undergoing Radical Cystectomy.
- Restaging transurethral resection for non-muscle invasive Bladder cancer: who, why, when, and how?
- Imaging the clear Cell renal Cell carcinoma proteome.
- Ureteroenteric anastomotic strictures after radical cystectomy-does operative approach matter?
- Salvage robotic assisted laparoscopic radical Prostatectomy: a single institution, 5-year experience.
- Anatomic basis for lymph node counts as measure of lymph node dissection extent: a cadaveric study.
- Volume outcomes of cystectomy--is it the surgeon or the setting?
- Inferior Vena Cava Filter Strut Perforation Discovered During Right Robotic-assisted Laparoscopic Partial Nephrectomy.
- The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for Bladder cancer.
- Predicting the probability of 90-day survival of elderly patients with Bladder cancer treated with radical cystectomy.
- Reply to Sabine Brookman-May, Maximilian Burger, and Matthias May's Letter to the Editor re: Todd M. Morgan, Dominic Tang, Kelly L. Stratton, et al. Preoperative Nutri...
- Urinary Collecting System Invasion Is a Predictor for Overall and Disease-specific Survival in Locally Invasive Renal Cell Carcinoma.
- Bladder cancer.
- Ductal adenoCarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen.
- The impact of residency match information disseminated by a third-party website.
- Disseminated tumor Cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence.
- Primary scrotal Cancer: disease characteristics and increasing incidence.
- Genomic alterations indicate tumor origin and varied metastatic potential of disseminated Cells from prostate cancer patients.
- RAD001 (Everolimus) inhibits growth of prostate Cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid.
- Complications of scrotal surgery for benign conditions.
- Detection and characterization of circulating and disseminated prostate cancer Cells.
- Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal Cell carcinoma.
- Targeted therapy for advanced prostate Cancer: inhibition of the PI3K/Akt/mTOR pathway.
- Hairpin-bisulfite PCR: assessing epigenetic methylation patterns on complementary strands of individual DNA molecules.
- Thymic stromal organization is regulated by the specificity of T Cell receptor/major histocompatibility complex interactions.
- A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate Cancer-specific death for patients receiving salvage radiation therapy...
- Independent Surgical Validation of the New Prostate Cancer Grade Grouping System.
Schools
HARVARD MED SCH
University of Washington
Vanderbilt University
Harvard University
Procedures Preformed
- AdRenalectomy
- Complete Nephrectomy With Robotic Assistance
- Cystectomy
- Cystometry
- View All
Conditions Treated
- Anemia
- Basal Cell Carcinoma
- Bladder Cancer
- Bladder Infection
- View All
Doctors Specialties
- Oncology
- Urology
Accepted Insurances
Awards
- Outstanding Reviewer in Prostate Cancer
- CMS Meaningful Use Stage 1 Certification
- Best Poster
- Best of AUA/JUA Annual Meeting
- Gerald P. Murphy Scholar
- CaPSURE™ Scholar
- International Volunteers in Urology Scholar
- Scholar-in-Training Award
- Warren H. Chapman Research Award
- First Prize Poster
- First Prize Resident Paper
- Young Investigator Award
Education
-
University of Washington -
Harvard Medical School -
Harvard University
Hospital
-
Vanderbilt Hospital and Clinics -
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1356452684 | |
| NPPES Provider LastName | MORGAN | |
| NPPES Provider FirstName | TODD | |
| NPPES Provider ZIPCode | 481095913 | |
| NPPES Provider State | MI | |
| Specialty Description | Urology | |
| Total Claim Count | 117.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1356452684 |
| Last Name Of The Provider | MORGAN |
| First Name Of The Provider | TODD |
| View All |
Similar Doctors
|
Dr. Ganesh S. Palapattu, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Henry A. Buchtel IV, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William W. Roberts III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert H. Moyad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher P. Filson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David P. Wood Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Noah E. Canvasser, MD |
|
|
Dr. Alison M. Lake, MD |
|
|
Dr. Miriam Hadj-Moussa, MD |
|
|
Dr. Amy N. Luckenbaugh, MD |
|
|
Dr. Sapan N. Ambani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hung-Jui Tan, MD |
|
|
Khaled S. Hafez, MB BCH
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sara M. Lenherr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joanne A. Lundgren, MD
This Doctor is OpenDoctor Recommended.
|